Literature DB >> 23174408

Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.

Nirmal Marasini1, Tuan Hiep Tran, Bijay Kumar Poudel, Hyuk Jun Cho, Young Keun Choi, Sang-Cheol Chi, Han-Gon Choi, Chul Soon Yong, Jong Oh Kim.   

Abstract

The present study was undertaken to overcome the problems associated with solubility, dissolution and oral bioavailability of a poorly water-soluble ionizable drug, telmisartan (TMS). For these purposes, a solubility test was carried to select the appropriate formulation composition from various carriers and alkalizers. Solid dispersions (SDs) of TMS were prepared at different drug-to-carrier ratios by the spray-drying technique, and were characterized by dissolution and aqueous solubility studies. The optimum formulation was investigated by dissolution studies at different pH and water media and its solid state characterisations were performed by scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and X-ray diffraction (XRD) studies. In solubility and dissolution tests, all TMS-loaded pH-modulated SDs (pH(M)-SDs) exhibited marked improvement in the dissolution behavior when compared with crystalline TMS powder. The optimum formulation of pH(M)-SD consisted of TMS/PVP (polyvinylpyrrolidone) K30/Na(2)CO(3) at a weight ratio of 2/0.5/3 and showed significant improvement in the aqueous solubility and dissolution rate by approximately 40,000- and 3-fold, respectively, compared to TMS powder. Solid-state characterization revealed the changed in crystallinity of TMS into amorphous state. Furthermore, area under the drug concentration time-curve (AUC) of TMS from the pH(M)-SD increased by 13.4- and 2.1-fold, compared with TMS powder and commercial product, respectively. According to these observations, taken together with dissolution and pharmacokinetic behaviors, pH-modulated SD in the presence of an alkalizer for a poorly water-soluble ionizable drug, TMS, appeared to be efficacious for enhancing its bioavailability.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174408     DOI: 10.1016/j.ijpharm.2012.11.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.

Authors:  Tuan Hiep Tran; Tuan Duc Nguyen; Bijay Kumar Poudel; Hanh Thuy Nguyen; Jong Oh Kim; Chul Soon Yong; Chien Ngoc Nguyen
Journal:  AAPS PharmSciTech       Date:  2015-03-19       Impact factor: 3.246

2.  Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement.

Authors:  Mai Khanfar; Mayyas Al-Remawi; Faisal Al-Akayleh; Suha Hmouze
Journal:  AAPS PharmSciTech       Date:  2021-03-21       Impact factor: 3.246

3.  Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.

Authors:  Sandeep Sarabu; Venkata Raman Kallakunta; Suresh Bandari; Amol Batra; Vivian Bi; Thomas Durig; Feng Zhang; Michael A Repka
Journal:  Carbohydr Polym       Date:  2020-01-10       Impact factor: 9.381

4.  In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.

Authors:  Yue Cao; Li-Li Shi; Qing-Ri Cao; Mingshi Yang; Jing-Hao Cui
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Characterization and Bioavailability Study of Baicalin-mesoporous Carbon Nanopowder Solid Dispersion.

Authors:  Li Cui; E Sune; Jie Song; Jing Wang; Xiao-Bin Jia; Zhen-Hai Zhang
Journal:  Pharmacogn Mag       Date:  2016 Oct-Dec       Impact factor: 1.085

Review 6.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

7.  Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design.

Authors:  Ho Yong Son; Bo Ram Chae; Ji Yeh Choi; Dong Jun Shin; Yoon Tae Goo; Eun Seok Lee; Tae Hoon Kang; Chang Hyun Kim; Ho Yub Yoon; Young Wook Choi
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

8.  Manufacturing Different Types of Solid Dispersions of BCS Class IV Polyphenol (Daidzein) by Spray Drying: Formulation and Bioavailability.

Authors:  Gean Pier Panizzon; Fernanda Giacomini Bueno; Tânia Ueda-Nakamura; Celso Vataru Nakamura; Benedito Prado Dias Filho
Journal:  Pharmaceutics       Date:  2019-09-25       Impact factor: 6.321

9.  Formulation and In Vitro Evaluation of Telmisartan Nanoparticles Prepared by Emulsion-Solvent Evaporation Technique.

Authors:  Naile ÖztÜrk; Aslı Kara; İmran Vural
Journal:  Turk J Pharm Sci       Date:  2020-10-30

10.  Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion.

Authors:  Shu-min Ding; Zhen-hai Zhang; Jie Song; Xu-dong Cheng; Jun Jiang; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.